Randomized trial · people
HGH: 9.78 cm/year growth vs 10.10 on weekly somatrogon
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In young children with growth hormone deficiency, daily somatropin and a once-weekly long-acting version produced similar first-year growth with similar side effect rates.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 228
- Published
- 2022
- Journal
- J Clin Endocrinol Metab
What they tested
The team tested whether once-weekly somatrogon, a long-acting growth hormone, works at least as well and as safely as once-daily somatropin in young children with growth hormone deficiency.
How the study was done
An open-label, randomized phase 3 trial in 228 children who had not yet reached puberty, had growth hormone deficiency and had never been treated with growth hormone. They got either weekly somatrogon (0.66 mg/kg/week arm) or daily somatropin (0.24 mg/kg/week arm) for 12 months. Open-label means families and doctors knew which drug was given.

What they found
At 12 months, children on somatrogon grew at 10.10 cm/year and those on somatropin at 9.78 cm/year, a difference of 0.33 (95% CI: -0.24, 0.89). The whole range stayed above the preset noninferiority margin of -1.8 cm/year, so weekly somatrogon counted as no worse than daily somatropin. Growth rate at 6 months and change in height standard deviation score (how height compares with peers) at 6 and 12 months were similar in both groups. Mild to moderate side effects showed up at similar rates: 78.9% on somatrogon and 79.1% on somatropin.
What it doesn’t show
It ran for only 12 months and was open-label, so knowing the treatment could have colored reports. It included only prepubertal children new to growth hormone, so it says nothing about adults, teens or people switching drugs.
The paper
Deal et al. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. J Clin Endocrinol Metab. 2022.
The compound
More studies on HGH
- HGH: long-acting PEG form beat daily HGH on height at 12 monthsMeta-analysis · people · 2025
- HGH: adult burn wounds healed 9.07 days faster in a meta-analysisMeta-analysis · people · 2014
- HGH: weekly Pegpesen matched daily rhGH on growth in childrenRandomized trial · people · 2025
- HGH: weekly somatrogon 9.65 vs daily 7.87 cm/year in GHD childrenRandomized trial · people · 2022
- HGH: liver fat 3.3% lower at 24 weeks vs no treatment, not significantRandomized trial · people · 2021
- HGH: MoCA cognition score rose from 16.31 to 21.19 after strokeRandomized trial · people · 2020
- Every study on HGH
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.